Harmony Biosciences Holdings (HRMY) Net Margin (2020 - 2025)
Historic Net Margin for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to 21.24%.
- Harmony Biosciences Holdings' Net Margin fell 35300.0% to 21.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.09%, marking a year-over-year increase of 30700.0%. This contributed to the annual value of 16.44% for FY2024, which is 57000.0% down from last year.
- According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Net Margin is 21.24%, which was down 35300.0% from 19.84% recorded in Q2 2025.
- In the past 5 years, Harmony Biosciences Holdings' Net Margin registered a high of 75.03% during Q3 2022, and its lowest value of 11.92% during Q3 2021.
- Over the past 5 years, Harmony Biosciences Holdings' median Net Margin value was 24.0% (recorded in 2023), while the average stood at 22.07%.
- In the last 5 years, Harmony Biosciences Holdings' Net Margin soared by 2596800bps in 2021 and then crashed by -510300bps in 2023.
- Harmony Biosciences Holdings' Net Margin (Quarter) stood at 24.9% in 2021, then soared by 52bps to 37.81% in 2022, then tumbled by -79bps to 7.83% in 2023, then skyrocketed by 36bps to 10.67% in 2024, then skyrocketed by 99bps to 21.24% in 2025.
- Its Net Margin stands at 21.24% for Q3 2025, versus 19.84% for Q2 2025 and 24.66% for Q1 2025.